90 results
8-K/A
ABBV
Abbvie Inc
8 May 24
Departure of Directors or Certain Officers
5:00pm
equal to 150% of his base salary, subject to the attainment of one or more pre-established performance targets.
Mr. Gonzalez’s new compensation … salary, subject to the attainment of one or more pre-established performance targets.
Item 5.07
Submission of Matters to a Vote of Security Holders
8-K
EX-99.1
ABBV
Abbvie Inc
2 Feb 24
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
7:51am
candidates for discovery targets selected by AbbVie.
AbbVie announced the launch of Produodopa (foslevodopa/foscarbidopa) in the European Union (EU … for multiple therapeutic targets.
Full-Year 2024 Outlook
AbbVie is issuing its adjusted diluted EPS guidance for the full-year 2024 of $11.05
8-K
EX-99.2
0grg3
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
EX-99.2
nmgx2i
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
PX14A6G
5zahtfka
11 Apr 23
Letter to shareholders
12:34pm
PX14A6G
ynz 77xd7jkp
30 Mar 22
Letter to shareholders
4:39pm
8-K
EX-99.1
a8zg c6x89
30 Apr 21
AbbVie Reports First-Quarter 2021 Financial Results
7:44am